David Gaiero

Directeur Financier/CFO chez CYTEIR THERAPEUTICS, INC.

Fortune : 308 197 $ au 31/03/2024

45 ans

Health Technology

Consumer Services

Postes actifs de David Gaiero

Sociétés	Poste	Début	Fin
CYTEIR THERAPEUTICS, INC.	Directeur Financier/CFO	01/12/2020	-
CYTEIR THERAPEUTICS, INC.	Treasurer	16/03/2022	-

Sociétés	Poste	Début	Fin
WAVE LIFE SCIENCES LTD.	Comptroller/Controller/Auditor	01/07/2017	04/12/2020
WAVE LIFE SCIENCES LTD.	Directeur Financier/CFO	09/01/2020	04/12/2020
OvaScience, Inc. OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.	Comptroller/Controller/Auditor	01/01/2015	01/01/2017

University of Massachusetts

Undergraduate Degree

Internationale

Etats-Unis	4
Singapour	2

Opérationnelle

Comptroller/Controller/Auditor	2
Director of Finance/CFO	2
Undergraduate Degree	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
WAVE LIFE SCIENCES LTD.	Health Technology
CYTEIR THERAPEUTICS, INC.	Health Technology

Entreprise privées	1
OvaScience, Inc. OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.	Health Technology

Entreprise privées

Health Technology